Bilal Hameed, MD

Hepatologist

Dr. Bilal Hameed is a hepatologist, or liver specialist, who treats patients with liver disease including patients before and after undergoing liver transplants. He is board certified by the American Board of Internal Medicine with a general certificate in internal medicine and a subspeciality in gastroenterology.

Hameed earned a medical degree at Dow Medical College in Pakistan and completed an internal medicine residency at the University of Minnesota. He completed consecutive fellowships at the University of Minnesota and UCSF in gastroenterology and transplant hepatology. He is a member of the American Association for the Study of Liver Diseases, American Gastroenterological Association and American Society of Transplantation. He is the author of numerous peer-reviewed articles and the recipient of many awards and honors in his field. Hameed, who is fluent in the Punjabi and Urdu languages, is an associate professor of medicine at UCSF.

Clinics

Liver Disease and Liver Transplant
350 Parnassus Ave., Suite 300
San Francisco, CA 94143
Phone: (415) 353-2318
Fax: (415) 353-2407

Hours: Monday to Friday
8:30 a.m. – 4:30 p.m.

Board Certification

Gastroenterology, American Board of Internal Medicine
Transplant Hepatology, American Board of Internal Medicine

Academic Title

Associate Professor

More about Bilal Hameed

Additional Languages

Punjabi
Urdu

Education

Dow School of Medicine 2000

Residencies

University of Minnesota, Internal Medicine 2006

Fellowships

University of Minnesota, Gastroenterology 2009
UCSF Medical Center, Transplant Hepatology 2010

Selected Research and Publications

  1. Stravitz RT, Gottfried M, Durkalski V, Fontana RJ, Hanje AJ, Koch D, Hameed B, Ganger D, Subramanian RM, Bukofzer S, Ravis WR, Clasen K, Sherker A, Little L, Lee WM. Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia. Hepatology. 2018 Mar; 67(3):1003-1013.
  2. Hameed B, Terrault NA, Gill RM, Loomba R, Chalasani N, Hoofnagle JH, Van Natta ML. Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2018 Mar; 47(5):645-656.
  3. Kotwani P, Saxena V, Dodge JL, Roberts J, Yao F, Hameed B. History of marijuana use does not affect outcomes on the liver transplant waitlist. Transplantation. 2018 Jan 10.
  4. Rubin JB, Hameed B, Gottfried M, Lee WM, Sarkar M. Acetaminophen-induced Acute Liver Failure Is More Common and More Severe in Women. Clin Gastroenterol Hepatol. 2017 Dec 02.
  5. Reuben A, Tillman H, Fontana RJ, Davern T, McGuire B, Stravitz RT, Durkalski V, Larson AM, Liou I, Fix O, Schilsky M, McCashland T, Hay JE, Murray N, Shaikh OS, Ganger D, Zaman A, Han SB, Chung RT, Smith A, Brown R, Crippin J, Harrison ME, Koch D, Munoz S, Reddy KR, Rossaro L, Satyanarayana R, Hassanein T, Hanje AJ, Olson J, Subramanian R, Karvellas C, Hameed B, Sherker AH, Robuck P, Lee WM. Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study. Ann Intern Med. 2016 Jun 07; 164(11):724-32.
  6. Karvellas CJ, Tillman H, Leung AA, Lee WM, Schilsky ML, Hameed B, Stravitz RT, McGuire BM, Fix OK. Acute liver injury and acute liver failure from mushroom poisoning in North America. Liver Int. 2016 07; 36(7):1043-50.
  7. Hameed B, Terrault N. Emerging Therapies for Nonalcoholic Fatty Liver Disease. Clin Liver Dis. 2016 May; 20(2):365-85.
  8. Azhar M, Sheikh AS, Khan A, Mustafa S, Shah IA, Hameed B. HEPATOBILIARY ASCARIASIS COMPLICATED BY PANCREATITIS. J Ayub Med Coll Abbottabad. 2015 Apr-Jun; 27(2):479-81.
  9. Kelley RK, Magbanua MJ, Butler TM, Collisson EA, Hwang J, Sidiropoulos N, Evason K, McWhirter RM, Hameed B, Wayne EM, Yao FY, Venook AP, Park JW. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls. BMC Cancer. 2015 Mar 31; 15:206.
  10. Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology. 2015 Jun; 61(6):1968-77.
  11. Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, Chalasani N, Dasarathy S, Diehl AM, Hameed B, Kowdley KV, McCullough A, Terrault N, Clark JM, Tonascia J, Brunt EM, Kleiner DE, Doo E. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet. 2015 Mar 14; 385(9972):956-65.
  12. Yao FY, Hameed B, Mehta N, Roberts JP. Response to letter to the editors. Liver Transpl. 2014 Oct; 20(10):1285.
  13. Sharpton SR, Feng S, Hameed B, Yao F, Lai JC. Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes. Transplantation. 2014 Sep 15; 98(5):557-62.
  14. Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl. 2014 Aug; 20(8):945-51.
  15. Mendelsohn BA, Mehta N, Hameed B, Pekmezci M, Packman S, Ralph J. Adult-Onset Fatal Neurohepatopathy in a Woman Caused by MPV17 Mutation. JIMD Rep. 2014; 13:37-41.
  16. Noureddin M, Yates KP, Vaughn IA, Neuschwander-Tetri BA, Sanyal AJ, McCullough A, Merriman R, Hameed B, Doo E, Kleiner DE, Behling C, Loomba R. Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology. 2013 Nov; 58(5):1644-54.
  17. Hassan A, Hameed B, Islam M, Khealani B, Khan M, Shafqat S. Clinical predictors of EMG-confirmed cervical and lumbosacral radiculopathy. Can J Neurol Sci. 2013 Mar; 40(2):219-24.
  18. Sebastian J, Derksen C, Khan K, Ibrahim M, Hameed B, Siddiqui M, Chow M, Findlay JM, Shuaib A, Saqqur M. Derivation of transcranial Doppler criteria for angiographically proven middle cerebral artery vasospasm after aneurysmal subarachnoid hemorrhage. J Neuroimaging. 2013 Oct; 23(4):489-94.
  19. Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault NA. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality. Liver Int. 2012 Jan; 32(1):158-64.
  20. Asdaghi N, Hameed B, Saini M, Jeerakathil T, Emery D, Butcher K. Acute perfusion and diffusion abnormalities predict early new MRI lesions 1 week after minor stroke and transient ischemic attack. Stroke. 2011 Aug; 42(8):2191-5.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.